ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sofinnova sells Breath Therapeutics to Zambon in $550m deal
July 29, 2019Venture capital firm Sofinnova Partners has dispossessed its portfolio company Breath Therapeutics to Italian pharmaceutical firm Zambon for a total consideration of up to $550m (€500m), including a €140m upfront payment. -
Zambon Acquires Sofinnova Partners’ Breath Therapeutics
July 26, 2019Italian pharma company purchases Breath Therapeutics for €500 million, with €140 million up front. -
Sofinnova, LSP lead $17M round for gene therapy player XyloCor
December 29, 2018XyloCor Therapeutics raised $17 million in its series A round to advance a gene therapy pipeline for cardiovascular disease. Its lead asset is a treatment for angina that is poised to enter the clinic in 2019....
Pharma Sources Insight January 2025
